Influence of hydrophobicity on the antimicrobial activity of helical antimicrobial peptides: a study focusing on three mastoparans
- PMID: 39617871
- DOI: 10.1007/s11030-024-11046-w
Influence of hydrophobicity on the antimicrobial activity of helical antimicrobial peptides: a study focusing on three mastoparans
Abstract
Hydrophobicity is crucial for the interaction between amphipathic antimicrobial peptides and microbial pathogens. However, it is difficult to fully understand the impact of this factor because the biological functions are also influenced by other structural properties, including peptide length, net charge, hydrophilicity, secondary structure, and hydrophobic moment. This study compares three natural antimicrobial peptides-mastoparan C, mastoparan-AF, and mastoparan L-where hydrophobicity varies but other structural features remain nearly identical. Mastoparan C, the most hydrophobic peptide, displays the highest helical content and hemolytic activity, whereas mastoparan-AF, with slightly lower hydrophobicity, demonstrates superior selectivity. In contrast, mastoparan L, the least hydrophobic peptide, exhibits the weakest antimicrobial potency and lowest hemolytic activity, despite showing the least self-assembly. Overall, this study suggests that optimal hydrophobicity, rather than the highest value, enhances antimicrobial efficacy while minimizing hemolytic activity.
Keywords: Antimicrobial peptides; Hydrophobicity; Mastoparans; Structure–activity relationships.
© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
Declarations. Conflict of interest: We have no conflict of interest to declare. Informed consent: Not relevant.
Similar articles
-
Characterization of the Hemolytic Activity of Mastoparan Family Peptides from Wasp Venoms.Toxins (Basel). 2023 Sep 28;15(10):591. doi: 10.3390/toxins15100591. Toxins (Basel). 2023. PMID: 37888622 Free PMC article.
-
Unwrapping the structural and functional features of antimicrobial peptides from wasp venoms.Pharmacol Res. 2024 Feb;200:107069. doi: 10.1016/j.phrs.2024.107069. Epub 2024 Jan 12. Pharmacol Res. 2024. PMID: 38218356 Review.
-
Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan.Peptides. 2011 Oct;32(10):2027-36. doi: 10.1016/j.peptides.2011.08.015. Epub 2011 Aug 22. Peptides. 2011. PMID: 21884742
-
In Silico and In Vitro Structure-Activity Relationship of Mastoparan and Its Analogs.Molecules. 2022 Jan 16;27(2):561. doi: 10.3390/molecules27020561. Molecules. 2022. PMID: 35056876 Free PMC article.
-
Chemical and Biological Characteristics of Antimicrobial α-Helical Peptides Found in Solitary Wasp Venoms and Their Interactions with Model Membranes.Toxins (Basel). 2019 Sep 24;11(10):559. doi: 10.3390/toxins11100559. Toxins (Basel). 2019. PMID: 31554187 Free PMC article. Review.
Cited by
-
Broad-Spectrum Gramicidin S Derivatives with Potent Activity Against Multidrug-Resistant Gram-Negative ESKAPE Pathogens.Antibiotics (Basel). 2025 Apr 22;14(5):423. doi: 10.3390/antibiotics14050423. Antibiotics (Basel). 2025. PMID: 40426491 Free PMC article.
-
Antimicrobial Peptides from Porcine Blood Cruor Hydrolysates as a Promising Source of Antifungal Activity.Foods. 2024 Dec 24;14(1):8. doi: 10.3390/foods14010008. Foods. 2024. PMID: 39796298 Free PMC article.
-
The importance role of central proline to the antimicrobial potency and selectivity of indolicidin.Arch Microbiol. 2025 Mar 20;207(4):97. doi: 10.1007/s00203-025-04299-y. Arch Microbiol. 2025. PMID: 40113630
References
-
- Lazzaro BP, Zasloff M, Rolff J (2020) Antimicrobial peptides: application informed by evolution. Science 368:eaau5480. https://doi.org/10.1126/science.aau5480 - DOI - PubMed - PMC
-
- Shi G, Kang X, Dong F et al (2022) DRAMP 3.0: an enhanced comprehensive data repository of antimicrobial peptides. Nucleic Acids Res 50:D488–D496. https://doi.org/10.1093/nar/gkab651 - DOI - PubMed
-
- Li W, Separovic F, O’Brien-Simpson NM, Wade JD (2021) Chemically modified and conjugated antimicrobial peptides against superbugs. Chem Soc Rev 50:4932–4973. https://doi.org/10.1039/D0CS01026J - DOI - PubMed
-
- Luong HX, Thanh TT, Tran TH (2020) Antimicrobial peptides—advances in development of therapeutic applications. Life Sci 260:118407. https://doi.org/10.1016/j.lfs.2020.118407 - DOI - PubMed - PMC
-
- Mahlapuu M, Björn C, Ekblom J (2020) Antimicrobial peptides as therapeutic agents: opportunities and challenges. Crit Rev Biotechnol 40:978–992. https://doi.org/10.1080/07388551.2020.1796576 - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources